New drugs: beta blockers and sympathomimetics.
作者信息
Kaye C M
出版信息
Br Med J (Clin Res Ed). 1983 Apr 30;286(6375):1439. doi: 10.1136/bmj.286.6375.1439.
Abstract
摘要
相似文献
1
New drugs: beta blockers and sympathomimetics.新药：β受体阻滞剂和拟交感神经药。
Br Med J (Clin Res Ed). 1983 Apr 30;286(6375):1439. doi: 10.1136/bmj.286.6375.1439.
2
Preliminary study of the disposition in man of acebutolol and its metabolite, diacetolol, using a new stereoselective hplc method.使用一种新的立体选择性高效液相色谱法对醋丁洛尔及其代谢物双醋洛尔在人体中的处置进行的初步研究。
J Pharm Pharmacol. 1984 Apr;36(4):276-7. doi: 10.1111/j.2042-7158.1984.tb04370.x.
3
Preliminary observations on the excretion of acebutolol and its acetyl metabolite in the urine and faeces of man.
J Pharm Pharmacol. 1981 Jun;33(6):386-7. doi: 10.1111/j.2042-7158.1981.tb13811.x.
4
The effect of food and alcohol on the pharmacokinetics of acebutolol and its metabolite, diacetolol.食物和酒精对醋丁洛尔及其代谢物双醋洛尔药代动力学的影响。
Biopharm Drug Dispos. 1984 Jan-Mar;5(1):91-5. doi: 10.1002/bdd.2510050112.
5
The penetration of acebutolol and its major metabolite, diacetolol, into human cerebrospinal fluid and saliva.醋丁洛尔及其主要代谢物双醋洛尔在人脑脊液和唾液中的渗透情况。
Br J Clin Pharmacol. 1981 Sep;12(3):427-9. doi: 10.1111/j.1365-2125.1981.tb01239.x.
6
Plasma and urine concentrations of acebutolol and its acetyl metabolite in patients with renal functional impairment.肾功能损害患者中醋丁洛尔及其乙酰代谢物的血浆和尿液浓度。
N Z Med J. 1980 Apr 23;91(658):289-91.
7
Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study.肝病对醋丁洛尔和双醋洛尔药代动力学无影响：一项单剂量研究。
Biopharm Drug Dispos. 1985 Apr-Jun;6(2):131-7. doi: 10.1002/bdd.2510060204.
8
In vitro studies on the pharmacological properties of diacetolol, the major metabolite of acebutolol in man.醋丁洛尔在人体中的主要代谢产物双醋洛尔药理特性的体外研究。
Arch Int Pharmacodyn Ther. 1985 Jan;273(1):4-17.
9
Biophysical characterization of the drug-membrane interactions: the case of propranolol and acebutolol.药物-膜相互作用的生物物理特性分析：以普萘洛尔和醋丁洛尔为例。
Eur J Pharm Biopharm. 2013 May;84(1):183-91. doi: 10.1016/j.ejpb.2012.12.005. Epub 2013 Jan 2.
本文引用的文献
1
Observations on the clinical pharmacology and plasma concentrations of diacetolol, the major human metabolite of acebutolol.醋丁洛尔的主要人体代谢物双醋洛尔的临床药理学及血药浓度观察
Br J Clin Pharmacol. 1981 Oct;12(4):561-5. doi: 10.1111/j.1365-2125.1981.tb01265.x.
2
Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol.醋丁洛尔的主要代谢产物双醋洛尔的药代动力学和生物利用度。
Eur J Clin Pharmacol. 1981 Mar;19(4):287-92. doi: 10.1007/BF00562806.
3
The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.).盐酸醋丁洛尔单次口服给药（400毫克）后，以及多次口服给药期间和之后（400毫克，每日两次）在人体中的药代动力学。
Biopharm Drug Dispos. 1981 Apr-Jun;2(2):103-14. doi: 10.1002/bdd.2510020202.
4
Pharmacological properties of diacetolol (M & B 16,942), a major metabolite of acebutolol.醋丁洛尔的主要代谢产物双醋洛尔（M&B 16,942）的药理特性
Eur J Pharmacol. 1982 May 7;80(1):47-56. doi: 10.1016/0014-2999(82)90176-5.
Zotero 插件